ArticleScientific reports2025
A self-supervised learning method for detection of retinitis pigmentosa and Stargardt disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinitis pigmentosa (RP) and Stargardt Disease (STGD) are inherited retinal diseases that can seriously affect vision. In this study, we present a novel, two-phase self-supervised learning method that addresses the challenge of limited labeled data in medical image analysis. In the first phase, the model learns useful visual features from a large collection of unlabeled retinal images using self-supervised training. In the second phase, it is fine-tuned on a smaller set of labeled images for the classification of RP and STGD. Experimental results demonstrate that using 5844 unlabeled and 782 labeled fundus images showed that our method, based on the EfficientNet-B1 architecture, outperforms state-of-the-art supervised learning methods, achieving 98.15% accuracy and 99.68% AUC. The proposed method is flexible and scalable, making it well-suited for real-world applications where labeled data is scarce.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.